IDEAS home Printed from https://ideas.repec.org/a/igg/jsesd0/v10y2019i3p85-102.html
   My bibliography  Save this article

Evaluation of Anti-Cancer Oncology Medicines Pharmaceutical Companies Under Chain of Sustainable Procurement

Author

Listed:
  • Anoop Kumar Sahu

    (Department of Mechanical Engg, Madanapalle Institute of Technology and Science, Andhra Pradesh, India)

Abstract

Cancer is awful disease, which makes panicle network in the body system of patients. Cancer is characterized by abnormal and uncontrolled cell growth, which results in the formation of lumps or masses in body known as tumor. There are more than 100 types of cancers and each is classified according to the cell capacity and size. Globally, cancer is accepted as the second leading cause of death. As per a WHO report, cancer is responsible for 8.8 million deaths in 2015. Anti-cancer drugs or oncology medicines are employed in taking the care of different patients. At the present time, many pharmaceutical companies are active in producing oncology medicines. It is probed that by pharmaceutical scientists how cancer treatments under the scheduled time can save life of patients and a delay in treating cancer patients may have unseemly effects on the life of patients. The presented research focuses on two cases. The first was conducted at Jabalpur Hospital & Research Centre (JHRC), where a structure/model related to A-CMsP company is built for assessing the performance under chain of sustainable procurement criteria. The second research focuses on the benchmarking of two A-CMsP companies. A multi objective optimization approach is implemented, accompanied with vague modeling for computing the overall performance index of oncology medicines.

Suggested Citation

  • Anoop Kumar Sahu, 2019. "Evaluation of Anti-Cancer Oncology Medicines Pharmaceutical Companies Under Chain of Sustainable Procurement," International Journal of Social Ecology and Sustainable Development (IJSESD), IGI Global, vol. 10(3), pages 85-102, July.
    • Handle: RePEc:igg:jsesd0:v:10:y:2019:i:3:p:85-102
    as

    Download full text from publisher

    File URL: http://services.igi-global.com/resolvedoi/resolve.aspx?doi=10.4018/IJSESD.2019070106
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:igg:jsesd0:v:10:y:2019:i:3:p:85-102. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Journal Editor (email available below). General contact details of provider: https://www.igi-global.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.